- Home
- ATEC vs IDYA Comparison
ATEC vs IDYA Comparison
Compare ATEC & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATEC
- IDYA
- Stock Information
- Founded
- ATEC 1990
- IDYA 2015
- Country
- ATEC United States
- IDYA United States
- Employees
- ATEC N/A
- IDYA N/A
- Industry
- ATEC Medical/Dental Instruments
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- ATEC Health Care
- IDYA Health Care
- Exchange
- ATEC Nasdaq
- IDYA Nasdaq
- Market Cap
- ATEC 2.3B
- IDYA 2.3B
- IPO Year
- ATEC 2006
- IDYA 2019
- Fundamental
- Price
- ATEC $15.87
- IDYA $28.39
- Analyst Decision
- ATEC Strong Buy
- IDYA Buy
- Analyst Count
- ATEC 8
- IDYA 17
- Target Price
- ATEC $17.13
- IDYA $48.20
- AVG Volume (30 Days)
- ATEC 2.0M
- IDYA 1.3M
- Earning Date
- ATEC 10-30-2025
- IDYA 11-04-2025
- Dividend Yield
- ATEC N/A
- IDYA N/A
- EPS Growth
- ATEC N/A
- IDYA N/A
- EPS
- ATEC N/A
- IDYA N/A
- Revenue
- ATEC $682,236,000.00
- IDYA $7,000,000.00
- Revenue This Year
- ATEC $23.76
- IDYA $90.17
- Revenue Next Year
- ATEC $18.20
- IDYA $219.42
- P/E Ratio
- ATEC N/A
- IDYA N/A
- Revenue Growth
- ATEC 26.27
- IDYA N/A
- 52 Week Low
- ATEC $5.08
- IDYA $13.45
- 52 Week High
- ATEC $16.70
- IDYA $32.67
- Technical
- Relative Strength Index (RSI)
- ATEC 65.36
- IDYA 56.69
- Support Level
- ATEC $13.14
- IDYA $26.89
- Resistance Level
- ATEC $14.05
- IDYA $31.07
- Average True Range (ATR)
- ATEC 0.59
- IDYA 1.44
- MACD
- ATEC 0.26
- IDYA 0.07
- Stochastic Oscillator
- ATEC 97.67
- IDYA 46.81
About ATEC Alphatec Holdings Inc.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.